As of 2026-03-29, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.17) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -243.8%.
The range of the Relative Valuation is (0.22) - (0.13) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 12.2x | 12.2x |
| Forward P/E multiples | 6.8x - 6.8x | 6.8x |
| Fair Price | (0.22) - (0.13) | (0.17) |
| Upside | -282.7% - -204.8% | -243.8% |
| Date | P/E |